Skip to main content
NIH funding notice RFA-DA-18-002

Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)

Closed on January 23, 2018.

Posted
March 3, 2017
Close date
January 23, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,313,474 in first-year total cost, median $656,737.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 HXO-H (12)]2

Most frequent institutions

  1. DANA-FARBER CANCER INST1
  2. SCRIPPS RESEARCH INSTITUTE, THE1
Competing awards under RFA-DA-18-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Identification of small molecules for neurological complications of HIV and substance abuse comorbidity1R01DA046204-01SANNA, PIETRO PSPICER, TIMOTHY PATRICKSCRIPPS RESEARCH INSTITUTE, THE, CA$696,944ZDA1
2018Effects of marijuana use on inflammation and vascular injury in adults with HIV infection1R01DA046203-01GABUZDA, DANA H.DANA-FARBER CANCER INST, MA$616,530ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.